133 related articles for article (PubMed ID: 4281770)
1. Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.
Kikuchi M; Shoji M; Ishida N
J Antibiot (Tokyo); 1974 Oct; 27(10):766-74. PubMed ID: 4281770
[No Abstract] [Full Text] [Related]
2. Biological activities and physicochemical properties of pre-neocarzinostatin and UV-irradiated neocarzinostatin.
Iseki S; Koide Y; Ebina T; Ishida N
J Antibiot (Tokyo); 1980 Jan; 33(1):110-3. PubMed ID: 6445350
[No Abstract] [Full Text] [Related]
3. Selective tryptophan oxidation in the antitumor protein neocarzinostatin and effects on conformation and biological activity.
Samy TS; Atreyi M; Maeda H; Meienhofer J
Biochemistry; 1974 Feb; 13(5):1007-14. PubMed ID: 4813363
[No Abstract] [Full Text] [Related]
4. A facile method of purification of neocarzinostatin, an antitumor protein.
Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the stability of antitumor protein, neocarzinostatin. II. Stability of injection of neocarzinostatin (author's transl)].
Kono M; Ishii F; Haneda I; Koyama Y; Kikuchi M
Jpn J Antibiot; 1974 Dec; 27(6):715-24. PubMed ID: 4282495
[No Abstract] [Full Text] [Related]
6. NEOCARZINOSTATIN, AN ANTITUMOR ANTIBIOTIC OF HIGH MOLECULAR WEIGHT. ISOLATION, PHYSIOCHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.
ISHIDA N; MIYAZAKI K; KUMAGAI K; RIKIMARU M
J Antibiot (Tokyo); 1965 Mar; 18():68-76. PubMed ID: 14326086
[No Abstract] [Full Text] [Related]
7. Specific G2 block in HeLa-S3 cells by neocarzinostatin.
Ebina T; Otsuki K; Seto M; Ishida N
Eur J Cancer (1965); 1975 Mar; 11(3):155-8. PubMed ID: 124253
[No Abstract] [Full Text] [Related]
8. Inhibitors of proteolytic enzymes prevent the inactivation by blood of the protein antibiotic neocarzinostatin and its succinyl derivative.
Maeda H; Takeshita J
J Antibiot (Tokyo); 1976 Jan; 29(1):111-2. PubMed ID: 132416
[No Abstract] [Full Text] [Related]
9. [Screening for antagonistic agents to the lethal toxicity of neocarzinostatin. II. Effects of various drugs in inhibiting the toxicity of neocarzinostatin in vivo].
Ouchi M; Toriyama K; Matsumoto T; Baba T
Jpn J Antibiot; 1988 Jan; 41(1):105-15. PubMed ID: 2966869
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the stability of antitumor protein, neocarzinostatin. I. Stability of solution of neocarzinostatin (author's transl)].
Kono M; Haneda I; Koyama Y; Kikuchi M
Jpn J Antibiot; 1974 Dec; 27(6):707-14. PubMed ID: 4282494
[No Abstract] [Full Text] [Related]
11. Neocarzinostatin in cancer chemotherapy (review).
Maeda H
Anticancer Res; 1981; 1(3):175-86. PubMed ID: 6211130
[TBL] [Abstract][Full Text] [Related]
12. The clecarmycins, new antitumor antibiotics produced by Streptomyces: fermentation, isolation and biological properties.
Fujii N; Katsuyama T; Kobayashi E; Hara M; Nakano H
J Antibiot (Tokyo); 1995 Aug; 48(8):768-72. PubMed ID: 7592019
[TBL] [Abstract][Full Text] [Related]
13. A new antibiotic, setomimycin, produced by a strain of Streptomyces.
Omura S; Tanaka H; Iwai Y; Nishigaki K; Awaya J; Takahashi Y; Masuma R
J Antibiot (Tokyo); 1978 Nov; 31(11):1091-8. PubMed ID: 721705
[TBL] [Abstract][Full Text] [Related]
14. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
Oda T; Yamamoto H; Miki T; Maeda H
Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a new antitumor antibiotic OS-3256-B from Streptomyces candidus var. azaticus.
Satoh K; Komiyama K; Kitao C; Iwai Y; Atsumi K
J Antibiot (Tokyo); 1974 Aug; 27(8):620-5. PubMed ID: 4474156
[No Abstract] [Full Text] [Related]
16. A new antitumor antibiotic, kazusamycin.
Umezawa I; Komiyama K; Oka H; Okada K; Tomisaka S; Miyano T; Takano S
J Antibiot (Tokyo); 1984 Jul; 37(7):706-11. PubMed ID: 6432763
[TBL] [Abstract][Full Text] [Related]
17. Neocarzinostatin-induced breakdown of deoxyribonucleic acid in HeLa-S3 cells.
Ohtsuki K; Ishida N
J Antibiot (Tokyo); 1975 Feb; 28(2):143-8. PubMed ID: 1112766
[TBL] [Abstract][Full Text] [Related]
18. [Screening for the antagonizing agents against lethal toxicity of neocarzinostatin. I. Inhibitory effects of various drugs on the toxicity of neocarzinostatin in vitro and in vivo].
Ito A; Koide Y; Haneda I; Toriyama K; Ouchi M; Matsumoto T; Baba T
Jpn J Antibiot; 1985 Jan; 38(1):137-44. PubMed ID: 3157807
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of neocarzinostatin (NCS).
Koide Y; Ito A; Ishii F; Koyama Y; Edo K; Ishida N
J Antibiot (Tokyo); 1982 Jun; 35(6):766-9. PubMed ID: 6214537
[No Abstract] [Full Text] [Related]
20. Studies on a new antitumor antibiotic, largomycin. 3. Biological properties and antitumor activity of largomycin F-II.
Yamaguchi T; Seto M; Oura Y; Arai Y; Enomoto K
J Antibiot (Tokyo); 1970 Aug; 23(8):382-7. PubMed ID: 5453314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
